Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Ozone therapy might improve cancer treatment and reduce its side effects.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Electrospun scaffolds can improve healing in diabetic wounds.

Melatonin may protect ear cells from damage caused by nicotine.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The yeast Pityrosporum ovale can cause skin allergies and infections, and antifungal treatments like ketoconazole are effective against it.

Topical JAK inhibitors may help treat some skin conditions but need more research.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.